MAPK6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.295600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.641600E-01
Normal-vs-Stage2
3.905400E-01
Normal-vs-Stage3
8.150000E-01
Normal-vs-Stage4
8.018400E-02
Stage1-vs-Stage2
9.175200E-01
Stage1-vs-Stage3
6.250200E-01
Stage1-vs-Stage4
4.357400E-01
Stage2-vs-Stage3
5.265600E-01
Stage2-vs-Stage4
2.713000E-01
Stage3-vs-Stage4
2.243000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.400400E-01
Normal-vs-AfricanAmerican
2.529000E-01
Normal-vs-Asian
5.721000E-01
Caucasian-vs-AfricanAmerican
4.247400E-01
Caucasian-vs-Asian
9.712200E-01
AfricanAmerican-vs-Asian
5.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.182400E-01
Normal-vs-Female
4.483000E-01
Male-vs-Female
5.819800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.376800E-01
Normal-vs-Age(41-60Yrs)
2.594800E-01
Normal-vs-Age(61-80Yrs)
5.094400E-01
Normal-vs-Age(81-100Yrs)
7.403200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.912800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.142200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.670400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.182500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.201010E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.336800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.972800E-01
Normal-vs-Daily Drinker
7.117400E-01
Normal-vs-Weekly Drinker
5.194600E-01
Normal-vs-Occasional Drinker
3.599400E-01
Normal-vs-Social Drinker
4.892200E-01
Non Drinker-vs-Daily Drinker
5.213400E-01
Non Drinker-vs-Weekly Drinker
9.216600E-01
Non Drinker-vs-Occasional Drinker
4.162400E-01
Non Drinker-vs-Social Drinker
8.066800E-01
Daily Drinker-vs-Weekly Drinker
6.536000E-01
Daily Drinker-vs-Occasional Drinker
2.054400E-01
Daily Drinker-vs-Social Drinker
7.219000E-01
Weekly Drinker-vs-Occasional Drinker
4.510000E-01
Weekly Drinker-vs-Social Drinker
8.974000E-01
Occasional Drinker-vs-Social Drinker
3.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.492630E-01
Normal-vs-Grade 2
2.997600E-02
Normal-vs-Grade 3
1.188020E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.500000E-02
Grade 1-vs-Grade 3
6.981800E-02
Grade 1-vs-Grade 4
1.492630E-01
Grade 2-vs-Grade 3
8.147200E-01
Grade 2-vs-Grade 4
2.997600E-02
Grade 3-vs-Grade 4
1.188020E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.100400E-01
Normal-vs-NonDiabetic
4.359000E-01
Diabetic-vs-NonDiabetic
2.389200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.493600E-01
Normal-vs-NoPancreatitis
4.877800E-01
Pancreatitis-vs-NoPancreatitis
8.680200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.686000E-01
Normal-vs-N1
3.885200E-01
N0-vs-N1
5.958800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.289400E-01
Normal-vs-TP53-NonMutant
5.560600E-01
TP53-Mutant-vs-TP53-NonMutant
3.830400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
